Opus Genetics Inc.
IRD | NASDAQ
$3.67
+$0.02 (+0.55%)
At close: Oct 30, 2026, 4:00 PM ET
$3.68
+$0.01 (+0.27%)
After-hours:
Oct 30, 2026, 7:30 PM ET
+0.55%
(1D)No price chart data available for 1D timeframe.
Rating
34.5
+5.0 ptsFundamentals Weak
Market Sentiment Neutral
Moat None
Sector Rank #669/1028 (Top 65%)
Key Statistics
Market Data
Market Cap $305.33M
1D Range
3.43 3.69
52W Range
1.74 6.07
Valuation (TTM)
PE -2.89
PB -23.51
EV/EBITDA -2.40
Valuation (NTM)
Forward PE N/A
Forward PEG -0.05
Price Target $12.60
Cash Flow
FCF Yield -13.3%
SBC Adj. FCF Yield -14.8%
SBC Impact -11.0%
Margins
Gross Margin 99.9%
Operating Margin -513.5%
FCF Margin -412.6%
Growth (CAGR)
Revenue 3Y | 5Y -39.8% |
150.5%
Dil EPS 3Y | 5Y -29.7% |
-34.7%
FCF 3Y | 5Y -52.2% |
-59.1%
Returns
ROA -115.8%
ROE 1147.6%
ROIC -59.3%
Financial Health
Net Cash
$53.88M
Current Ratio 12.19
Interest Coverage -19.11
Dividends
Div Yield N/A
Payout Ratio N/A
FCF Payout Ratio N/A
Loading financial charts...
Profile
Opus Genetics, Inc. is a clinical-stage biopharmaceutical company focused on ophthalmology. The company is dedicated to discovering and commercializing innovative therapies to address significant unme...
Sector Healthcare
Industry Biotechnology
Employees 28
IPO Date Jan 19, 2015
Website opusgtx.com
Fiscal Year January - December
Latest News
No news articles available yet.
Analyst Summary
# of Analysts
8
Consensus
Buy
Price Target
$10.00
Upside
+172.48%
Buy (8)
Hold (0)
Sell (0)
Add to Watchlist
Select watchlists to add or remove IRD